Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative
about
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionIndividualized Gaussian process-based prediction and detection of local and global gray matter abnormalities in elderly subjectsThe Alzheimer's disease neuroimaging initiative: progress report and future plansPulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI.White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findingsImaging small vessel-associated white matter changes in aging.Structural imaging measures of brain aging.White matter hyperintensities, cognitive impairment and dementia: an update.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Recent Advances in Leukoaraiosis: White Matter Structural Integrity and Functional Outcomes after Acute Ischemic Stroke.Comorbidity and progression of late onset Alzheimer's disease: A systematic review.Neglect performance in acute stroke is related to severity of white matter hyperintensities.Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studiesThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic study.Structural MRI in normal aging and Alzheimer's disease: white and black spots.Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.The declining infrastructure of the aging brain.Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease.White matter hyperintensities and imaging patterns of brain ageing in the general population.Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer diseaseSubcortical hyperintensity volumetrics in Alzheimer's disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory.Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.A new delirium phenotype with rapid high amplitude onset and nearly as rapid reversal: Central Coast Australia Delirium Intervention Study.Associations between T1 white matter lesion volume and regional white matter microstructure in aging.Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum.White matter hyperintensities among older adults are associated with futile increase in frontal activation and functional connectivity during spatial searchDementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.White matter lesions and brain gray matter volume in cognitively normal elders.Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component.Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
P2860
Q26801629-BED8001C-92C6-43B3-9E26-1456F41211B9Q26830740-4667702D-077A-47F8-AB25-E17BA11B6C7DQ27006831-F4FC131C-2C8D-4484-924F-C97E9E7CB5CCQ28656446-5872CD6F-3C32-4322-BACF-004E2F6C2E67Q28749585-59AB9575-006C-47BE-A5F5-E6C04BDD0E43Q30409644-7DD8D097-2250-460E-94AF-C07C0EDDF648Q30530793-6F451E54-112E-4D78-924F-1CB862C9777EQ30620060-BEBDAB9C-A378-4404-9F62-B0F6855EF4E7Q30655992-AFA69AE4-D6C6-4C46-A02E-7AC3C0FB041CQ30666527-A634CF88-1D63-41F7-8B3E-87920A845D5EQ30710587-4366419E-A91A-4446-AFD5-60AB0606076FQ30844186-8A46AAF4-B951-4580-8BAF-3BF92E9FF8F3Q30893715-470E59B3-EFF8-4C7F-AEAD-755842FA47E8Q30971403-A350B464-EC44-46DA-9C80-0303C95EF51CQ30981669-7EC3AA42-94A2-438C-97F6-37F0718FA771Q31140040-E96BD220-2E9B-4416-A5B6-440DA078AFC3Q33638042-B7B1C676-3E2B-4536-B708-1507B74EA74EQ33760741-39EC3099-C5A7-4DF7-9944-65A232C5CC01Q33934866-B930BB9F-E764-4A06-95A8-8DC6AF33D35AQ34065449-B05C0199-14F2-4000-B365-236948C9C50EQ34130449-016FE6DB-CA0D-4489-9767-5C3823B001ADQ34133555-4018B00D-68FB-4DC8-8941-0C6D82991A53Q34149357-6B2C89E2-C1A7-4012-B3EE-40686E19C0C8Q34203105-5ACECC4E-4956-4A2F-BF29-573698BA1CAFQ34407220-4028B4E2-D69B-4F29-A8F9-ECEC01D7D7EEQ34473063-668C39B1-BA25-41E7-B5C1-BED7DAD9BABAQ34515561-2E096ED7-7A73-42D4-B595-B38EC3360964Q34620948-B8CA85A0-2FDB-4323-B7A0-3102842D0E93Q34629862-9CA43D46-B578-4D25-BBFA-1B7729CFC9C2Q34714991-4EC31469-4B04-4AD3-BA34-36C06ACBB51EQ35019559-4203E6D5-DE33-4725-8DB1-2C504B16846FQ35105109-B7177142-A442-44F8-8382-13B5979A2C48Q35167352-820C9416-EC07-4A9C-9FCD-83866108FAE9Q35195389-16C1809B-8A35-404E-82FA-A3FDAA4793BAQ35203057-9935C333-A942-4DC7-861F-C1CE54FF4728Q35394390-E38CF73E-FDE1-434C-9441-D220CC363AC5Q35643285-7478FBA4-E0DF-4469-AA90-C8497704F2ADQ35758666-588017C8-ECB3-4428-8150-3E55778CB6CDQ35802554-F02486E7-0AF3-4648-B159-C05A5D7FF594Q35803904-7683B512-3400-45FE-BA33-9667BAB0F113
P2860
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Longitudinal changes in white ...... isease neuroimaging initiative
@ast
Longitudinal changes in white ...... isease neuroimaging initiative
@en
Longitudinal changes in white ...... isease neuroimaging initiative
@nl
type
label
Longitudinal changes in white ...... isease neuroimaging initiative
@ast
Longitudinal changes in white ...... isease neuroimaging initiative
@en
Longitudinal changes in white ...... isease neuroimaging initiative
@nl
prefLabel
Longitudinal changes in white ...... isease neuroimaging initiative
@ast
Longitudinal changes in white ...... isease neuroimaging initiative
@en
Longitudinal changes in white ...... isease neuroimaging initiative
@nl
P2093
P2860
P50
P1433
P1476
Longitudinal changes in white ...... isease neuroimaging initiative
@en
P2093
Danielle Harvey
David Drucker
Evan Fletcher
Owen Carmichael
P2860
P304
P356
10.1001/ARCHNEUROL.2010.284
P50
P577
2010-11-01T00:00:00Z